By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Akebia Therapeutics, Inc. 

9987 Carver Road
Suite 420
Cincinnati  Ohio  45242  U.S.A.
Phone: 513-618-0931 Fax: 513-618-0950


Company News
Why Akebia (AKBA), Even With Otsuka Pharma's Big Deal, May Need To Be Acquired 4/27/2017 7:07:32 AM
Otsuka Pharma Believes in Akebia (AKBA), Commits Another $865 Million to Expand Anemia Deal 4/26/2017 5:38:54 AM
Akebia (AKBA) Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 4/7/2017 7:43:14 AM
Akebia (AKBA) Announces Publication Of Phase IIa Results For Vadadustat In Patients With Anemia Related To Chronic Kidney Disease 3/28/2017 6:40:31 AM
Akebia (AKBA) Spinoff Aerpio Scores $40 Million 3/16/2017 6:33:20 AM
Akebia (AKBA) Announces Fourth Quarter And Full-Year 2016 Financial Results 3/7/2017 8:46:46 AM
Akebia (AKBA) To Host Conference Call On March 6th To Discuss Full-Year 2016 Financial Results And Corporate Highlights 3/1/2017 8:30:56 AM
Akebia (AKBA) Licenses Portfolio Of Novel HIF Compounds From Johnson & Johnson Innovation (JNJ) 2/13/2017 6:23:54 AM
Akebia (AKBA) Forges $1B U.S. Deal with Otsuka Pharma on Late-Stage Drug 12/20/2016 6:44:47 AM
Akebia (AKBA) Prevails in Additional European Patent Dispute 12/12/2016 10:31:47 AM